Mannkind Shares Dip After FDA Group Raises Afrezza Concerns
Shares of Mannkind slumped 1% on Friday in choppy trade after a report from FDA staff raised some questions about its diabetes device Afrezza.
You'll Soon be Able to Shop Around for Your Imaging Testing Services
We can compare prices on pretty much everything we buy nowadays, and experts predict we will soon be doing the same with our health-care needs.
Glaxo Cancer Vaccine Fails, Testing Continues
An experimental cancer vaccine from GlaxoSmithKline failed in a late-stage trial but the British drug company says it remains committed to the project.
How to Reduce the Time You Spent in the Doctor's Waiting Room
Wait times in doctors’ offices across the country are getting longer as physicians take on more patients, but that doesn’t mean you have to dedicate an entire morning for an appointment.
Pfizer Loses Bid to Hold Celebrex Exclusivity Until '15
Pfizer said a U.S. federal court struck down its reissue patent on Celebrex that would have extended the drugmaker's exclusivity on the drug.
How to Spot Medical Billing Errors
Some reports say 80% of medical bills contain errors--but finding these mistakes can be hard. Here's what you should be looking for.
FDA Gives Bristol-Myers' Hepatitis Drug 'Breakthrough' Designation
Bristol-Myers Squibb’s experimental treatment for hepatitis C infection was awarded rare “breakthrough therapy designation” on Monday by U.S. drug regulators.
GlaxoSmithKline's Lung Disease Drug Gets European Green Light
Anoro, a combination drug for chronic obstructive pulmonary disease (COPD) developed by GlaxoSmithKline and Theravance, has received the green light from a European medical committee, putting the companies on track for marketing approval.
3 Reasons Your Medical Records Are at Risk
Medical records are stored digitally, and patient privacy is not always top priority when data systems are designed.
Don’t Pay that Total. How to Negotiate Your Medical Bills
Just because a medical bill says you owe a certain amount--there is some wiggle room.
Merck Misses Estimates in 4Q; Plans Increased Focus on Cancer
Merck posted weaker-than-expected sales amid stronger competition from generic medicines, while the pharma heavyweight posted a full-year profit view that bracketed the Street's view.
How to Make the Cost of Your Prescriptions Cheaper
The cost of medicine has been on a steady climb, but that doesn’t mean you have to pay full price for your prescription drugs or compromise your health.
Could Your Medical Debt Keep You From Getting a Job?
Some employers use credit checks to screen potential employees. But what happens if the candidate had problems with medical debt?
Pfizer Tops 4Q Views on New Treatments, Emerging Markets
Pfizer reported better-than-expected fourth-quarter results, helped by sales of new treatments for cancer, nerve pain and arthritis.
Pfizer Lung Cancer Drug Fails Two Late-Stage Trials
Pfizer said its experimental lung cancer drug failed to meet its goals in two late-stage studies in patients who received prior treatment for advanced non-small cell lung cancer.
How Long Does it Take for a Medical Debt to Go to Collections?
Out-of-pocket healthcare costs for 2013 are estimated to have totaled $322 billion, and millions of medical debt accounts are sent to collection annually.
Obamacare and Your Health Savings Account
If you have an HSA, can you use it with a health plan bought through an exchange?
General Electric Scoops Up Thermo Fisher Assets for $1.06B
The scientific and lab equipment maker will sell part of its business to GE Healthcare for about $1.06 billion.
Resolve Medical Debt Before Marriage
It can be hard to start married life on the right financial footing with unpaid medical debt looming.
Health Insurance Costs Going Up?
There's a lot of confusion about the new health-care requirements. Here's a quick guide on what you need to know.



















